Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape

by Tanjina Kader, Prue Hill, Emad A. Rakha, Ian G. Campbell, Kylie L. Gorringe
Published 2018-05-01

Deciphering the Clinical Behaviour of Invasive Lobular Carcinoma of the Breast Defines an Aggressive Subtype

by Shorouk Makhlouf, Nehal M. Atallah, Susanna Polotto, Andrew H. S. Lee, Andrew R. Green, Emad A. Rakha
Published 2024-05-01

Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery

by Dustin W. Shipp, Emad A. Rakha, Alexey A. Koloydenko, R. Douglas Macmillan, Ian O. Ellis, Ioan Notingher
Published 2018-07-01

RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers

by Adel Alblihy, Muslim L. Alabdullah, Michael S. Toss, Mashael Algethami, Nigel P. Mongan, Emad A. Rakha, Srinivasan Madhusudan
Published 2020-12-01

CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer

by Radhika Aiyappa‐Maudsley, Sarah J Storr, Emad A Rakha, Andrew R Green, Ian O Ellis, Stewart G Martin
Published 2022-11-01

ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity

by Reem Ali, Muslim Alabdullah, Islam Miligy, Makhliyo Normatova, Roya Babaei-Jadidi, Abdolrahman S. Nateri, Emad A. Rakha, Srinivasan Madhusudan
Published 2019-10-01

XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib

by Reem Ali, Adel Alblihy, Michael S. Toss, Mashael Algethami, Rabab Al Sunni, Andrew R. Green, Emad A. Rakha, Srinivasan Madhusudan
Published 2020-12-01

Artificial intelligence in digital breast pathology: Techniques and applications

by Asmaa Ibrahim, Paul Gamble, Ronnachai Jaroensri, Mohammed M. Abdelsamea, Craig H. Mermel, Po-Hsuan Cameron Chen, Emad A. Rakha
Published 2020-02-01

Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers

by Adel Alblihy, Muslim L. Alabdullah, Reem Ali, Mashael Algethami, Michael S. Toss, Nigel P. Mongan, Emad A. Rakha, Srinivasan Madhusudan
Published 2021-01-01

Age-Related Biology of Early-Stage Operable Breast Cancer and Its Impact on Clinical Outcome

by Binafsha M. Syed, Andrew R. Green, Emad A. Rakha, David A.L. Morgan, Ian O. Ellis, Kwok-Leung Cheung
Published 2021-03-01

Clinicopathological Significance of Cyclin-Dependent Kinase 2 (CDK2) in Ductal Carcinoma In Situ and Early-Stage Invasive Breast Cancers

by Ayat Lashen, Shatha Alqahtani, Ahmed Shoqafi, Mashael Algethami, Jennie N. Jeyapalan, Nigel P. Mongan, Emad A. Rakha, Srinivasan Madhusudan
Published 2024-05-01

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer

by Lutfi H. Alfarsi, Rokaya El Ansari, Madeleine L. Craze, Brendah K. Masisi, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2020-05-01

Lessons from a breast cell annotation competition series for school pupils

by Wenqi Lu, Islam M. Miligy, Fayyaz Minhas, Young Saeng Park, David R. J. Snead, Emad A. Rakha, Clare Verrill, Nasir Rajpoot
Published 2022-05-01

The Clinicopathological Significance of the Cyclin D1/E1–Cyclin-Dependent Kinase (CDK2/4/6)–Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers

by Ayat Lashen, Mashael Algethami, Shatha Alqahtani, Ahmed Shoqafi, Amera Sheha, Jennie N. Jeyapalan, Nigel P. Mongan, Emad A. Rakha, Srinivasan Madhusudan
Published 2024-04-01

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

by Simon J. Johnston, Dena Ahmad, Mohammed A. Aleskandarany, Sasagu Kurozumi, Chris C. Nolan, Maria Diez-Rodriguez, Andrew R. Green, Emad A. Rakha
Published 2018-10-01

The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

by Rokaya El Ansari, Madeleine L. Craze, Islam Miligy, Maria Diez-Rodriguez, Christopher C. Nolan, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2018-03-01

Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer

by Lutfi H. Alfarsi, Rokaya El Ansari, Brendah K. Masisi, Ruth Parks, Omar J Mohammed, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2020-06-01

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer

by Yousif A. Kariri, Chitra Joseph, Mansour A. Alsaleem, Khloud A. Elsharawy, Sami Alsaeed, Michael S. Toss, Nigel P. Mongan, Andrew R. Green, Emad A. Rakha
Published 2022-11-01

Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer

by Lutfi H. Alfarsi, Rokaya El-Ansari, Madeleine L. Craze, Brendah K. Masisi, Omar J. Mohammed, Ian O. Ellis, Emad A. Rakha, Andrew R. Green
Published 2020-02-01

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer

by Brendah K. Masisi, Rokaya El Ansari, Lutfi Alfarsi, Madeleine L. Craze, Natasha Jewa, Andrew Oldfield, Hayley Cheung, Michael Toss, Emad A. Rakha, Andrew R. Green
Published 2021-08-01